Descriptor English: | Apoprotein(a) | ||||||
Descriptor Spanish: |
Apoproteína(a)
| ||||||
Descriptor Portuguese: | Apoproteína(a) | ||||||
Descriptor French: | Apoprotéine A | ||||||
Entry term(s): |
Antiangiogenic AK38 Protein Apo Lp(a) Apolipoprotein (a) Apolipoprotein Lp(a) Apolipoprotein Lp(a+) Apolipoprotein(a) Apoprotein (a) Protein, Antiangiogenic AK38 |
||||||
Tree number(s): |
D10.532.350.500 D12.776.521.400.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D053241 | ||||||
Scope note: | A large and highly glycosylated protein constituent of LIPOPROTEIN (A). It has very little affinity for lipids but forms disulfide-linkage to APOLIPOPROTEIN B-100. Apoprotein(a) has SERINE PROTEINASE activity and can be of varying sizes from 400- to 800-kDa. It is homologous to PLASMINOGEN and is known to modulate THROMBOSIS and FIBRINOLYSIS. |
||||||
Annotation: | do not confuse with APOLIPOPROTEINS A, normal structural proteins of the alpha-lipoproteins (HIGH DENSITY LIPOPROTEINS) |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Registry Number: | EC 3.4.21.- | ||||||
Previous Indexing: |
Apolipoproteins (1977-1993) Apolipoproteins A (1982-2006) Apoproteins (1978-2004) |
||||||
Public MeSH Note: | 2007; see APOLIPOPROTEINS A 1988-2006; APOLIPOPROTEIN LP(A+) was indexed under APOLIPOPROTEINS & LIPOPROTEIN(A) 1986-2006 |
||||||
History Note: | 2007 (1986); use APOLIPOPROTEINS A 1988-2006 |
||||||
DeCS ID: | 52270 | ||||||
Unique ID: | D053241 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2007/01/01 | ||||||
Date of Entry: | 2006/07/05 | ||||||
Revision Date: | 2009/07/20 |
-
-
CHEMICALS AND DRUGS
Lipids [D10]Lipids -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Apoprotein(a)
- Preferred
Concept UI |
M0001595 |
Scope note | A large and highly glycosylated protein constituent of LIPOPROTEIN (A). It has very little affinity for lipids but forms disulfide-linkage to APOLIPOPROTEIN B-100. Apoprotein(a) has SERINE PROTEINASE activity and can be of varying sizes from 400- to 800-kDa. It is homologous to PLASMINOGEN and is known to modulate THROMBOSIS and FIBRINOLYSIS. |
Preferred term | Apoprotein(a) |
Entry term(s) |
Antiangiogenic AK38 Protein Apo Lp(a) Apolipoprotein (a) Apolipoprotein Lp(a) Apolipoprotein Lp(a+) Apolipoprotein(a) Apoprotein (a) Protein, Antiangiogenic AK38 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey